Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 375 clinical trials
AUTO-REPLY  

AUTO-REPLY

  • 0 views
  • 21 Nov, 2022
  • 2 locations
  • 0 views
  • 01 Aug, 2022
  • 1 location
  • 0 views
  • 22 Dec, 2022
  • 5 locations
  • 0 views
  • 13 Dec, 2022
  • 1 location
A Study to Evaluate the Pharmacokinetics and Safety Between "BR3006" and Co-administration of "BR3006A", "BR3006B", and "BR3006C" in Healthy Adult Volunteers (Fed)  

This was an open-label, randomized, fed, single-dose, 2-sequence, 2- period crossover study to evaluate the pharmacokinetics and safety between single oral administration of "BR3006" and co-administration of "BR3006A", "BR3006B," and "BR3006C" in healthy adult volunteers.

Accepts healthy volunteers
  • 0 views
  • 05 Nov, 2025
  • 1 location
Preliminary Efficacy and Safety of Apremilast in the Treatment of Acne Conglobata (APACCO) updated  

Apremilast mediates its clinical effect through the cAMP-PKA-NFkappaB pathway which results in a clinical picture changes to a decrease of all signs of inflammation.Due to the NFkappaB mediated chronical inflammation in the pathogenesis of acne conglobata, a treatment with Apremilast seems to be an effective option.In this study, treatment with …

  • 0 views
  • 14 Mar, 2022
  • 4 locations
Study Test Site  

This is a 3-arm, randomized, double-blind, double-dummy, and controlled clinical study over 6 months of treatment to evaluate the metabolic and clinical efficacy as well as the safety of DLBS3233 alone, metformin and combination of both, in improving metabolic and reproductive parameters.

  • 0 views
  • 28 Sep, 2022
  • 2 locations
Phase 1 Study to Assess Safety and Tolerability of EO2002  

The goal of this clinical study is to assess the safety of intracameral injection of EO2002 in subjects post-cataract surgery.

  • 0 views
  • 25 Oct, 2022
  • 1 location
Analytics Superset testing, please dont change it (CHXLAS)  

This Phase 2 randomized controlled trial will study the safety, tolerability, and efficacy of Hydroxychloroquine in qualified patients with Alport syndrome. The trial will be open-label, randomized, controlled and will enroll up to 50 patients.

  • 0 views
  • 28 Feb, 2024
  • 1 location
  • 0 views
  • 25 Jan, 2023
  • 1 location